<unk>  is a HMG-CoA reductase inhibitor that is FDA approved for the treatment of hyperlipidemia and mixed dyslipidemia, hypertriglyceridemia, primary dysbetalipoproteinemia (Type III hyperlipoproteinemia), homozygous familial hypercholesterolemia, slowing of the progression of atherosclerosis, primary prevention of cardiovascular disease.   Common adverse reactions include headache, myalgia, abdominal pain, asthenia, and nausea.
Rosuvastatin
Lovastatin
Atorvastatin
Clofibrate
Pravastatin
Mevastatin
Fluvastatin
Fenofibrate